Invesco’s HUTCHMED HCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-12,174
Closed -$108K 4039
2022
Q3
$108K Sell
12,174
-1,955
-14% -$24.6K ﹤0.01% 3822
2022
Q2
$178K Sell
14,129
-2,878
-17% -$36.6K ﹤0.01% 3758
2022
Q1
$322K Buy
17,007
+2,609
+18% +$66.4K ﹤0.01% 3603
2021
Q4
$505K Sell
14,398
-817
-5% -$26.5K ﹤0.01% 3385
2021
Q3
$557K Buy
15,215
+3,619
+31% +$142K ﹤0.01% 3381
2021
Q2
$455K Buy
+11,596
New +$335K ﹤0.01% 3459
2020
Q2
Sell
-3,628,145
Closed -$64.8M 3659
2020
Q1
$64.8M Sell
3,628,145
-73,713
-2% -$1.78M 0.03% 682
2019
Q4
$92.8M Sell
3,701,858
-2,343
-0.1% -$51.3K 0.03% 700
2019
Q3
$66.1M Buy
3,704,201
+331
+0% +$6.89K 0.02% 853
2019
Q2
$81.5M Buy
+3,703,870
New +$106M 0.02% 776

Other funds holding HCM

Invesco's HCM Position: Q4 2022 in Review

Invesco sold out of HUTCHMED (HCM) in Q4 2022, closing a stake of 12,174 shares — an estimated $108K sold.

Invesco first reported a position in HCM in Q2 2019 and held it in 10 quarters. The position peaked at $92.8M in Q4 2019. 84 funds tracked by Wall St. Rank hold HCM as of Q4 2022.

  • Invesco reported no remaining HUTCHMED position as of Q4 2022 after selling out during the quarter.
  • Invesco sold 12,174 HUTCHMED shares in Q4 2022, an estimated $108K.
  • Invesco first reported a position in HUTCHMED in Q2 2019 and held it in 10 quarters.
  • Invesco's HUTCHMED position peaked at $92.8M in Q4 2019.
  • 84 funds tracked by Wall St. Rank held HUTCHMED as of Q4 2022.

Based on Invesco's 13F filing for Q4 2022, filed 13 Feb 2023.